Global Human Injection Flu Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Injection Flu Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Injection Flu Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Injection Flu Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Human Injection Flu Vaccine Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Human Injection Flu Vaccine Sales by Type

2.3.1 Global Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Human Injection Flu Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Injection Flu Vaccine Sale Price by Type (2017-2022)

2.4 Human Injection Flu Vaccine Segment by Application

2.4.1 6 Months to 3 Years

2.4.2 > 3 Years

2.5 Human Injection Flu Vaccine Sales by Application

2.5.1 Global Human Injection Flu Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Human Injection Flu Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Injection Flu Vaccine Sale Price by Application (2017-2022)

3 Global Human Injection Flu Vaccine by Company

3.1 Global Human Injection Flu Vaccine Breakdown Data by Company

3.1.1 Global Human Injection Flu Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Human Injection Flu Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Human Injection Flu Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Human Injection Flu Vaccine Revenue by Company (2020-2022)

3.2.2 Global Human Injection Flu Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Human Injection Flu Vaccine Sale Price by Company

3.4 Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Injection Flu Vaccine Product Location Distribution

3.4.2 Players Human Injection Flu Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Injection Flu Vaccine by Geographic Region

4.1 World Historic Human Injection Flu Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Injection Flu Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Injection Flu Vaccine Annual Revenue by Geographic Region

4.2 World Historic Human Injection Flu Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Human Injection Flu Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Injection Flu Vaccine Annual Revenue by Country/Region

4.3 Americas Human Injection Flu Vaccine Sales Growth

4.4 APAC Human Injection Flu Vaccine Sales Growth

4.5 Europe Human Injection Flu Vaccine Sales Growth

4.6 Middle East & Africa Human Injection Flu Vaccine Sales Growth

5 Americas

5.1 Americas Human Injection Flu Vaccine Sales by Country

5.1.1 Americas Human Injection Flu Vaccine Sales by Country (2017-2022)

5.1.2 Americas Human Injection Flu Vaccine Revenue by Country (2017-2022)

5.2 Americas Human Injection Flu Vaccine Sales by Type

5.3 Americas Human Injection Flu Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Injection Flu Vaccine Sales by Region

6.1.1 APAC Human Injection Flu Vaccine Sales by Region (2017-2022)

6.1.2 APAC Human Injection Flu Vaccine Revenue by Region (2017-2022)

6.2 APAC Human Injection Flu Vaccine Sales by Type

6.3 APAC Human Injection Flu Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Injection Flu Vaccine by Country

7.1.1 Europe Human Injection Flu Vaccine Sales by Country (2017-2022)

7.1.2 Europe Human Injection Flu Vaccine Revenue by Country (2017-2022)

7.2 Europe Human Injection Flu Vaccine Sales by Type

7.3 Europe Human Injection Flu Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Injection Flu Vaccine by Country

8.1.1 Middle East & Africa Human Injection Flu Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Injection Flu Vaccine Sales by Type

8.3 Middle East & Africa Human Injection Flu Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine

10.3 Manufacturing Process Analysis of Human Injection Flu Vaccine

10.4 Industry Chain Structure of Human Injection Flu Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Injection Flu Vaccine Distributors

11.3 Human Injection Flu Vaccine Customer

12 World Forecast Review for Human Injection Flu Vaccine by Geographic Region

12.1 Global Human Injection Flu Vaccine Market Size Forecast by Region

12.1.1 Global Human Injection Flu Vaccine Forecast by Region (2023-2028)

12.1.2 Global Human Injection Flu Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Injection Flu Vaccine Forecast by Type

12.7 Global Human Injection Flu Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Human Injection Flu Vaccine Product Offered

13.1.3 Sanofi Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 CSL

13.2.1 CSL Company Information

13.2.2 CSL Human Injection Flu Vaccine Product Offered

13.2.3 CSL Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Main Business Overview

13.2.5 CSL Latest Developments

13.3 GSK

13.3.1 GSK Company Information

13.3.2 GSK Human Injection Flu Vaccine Product Offered

13.3.3 GSK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GSK Main Business Overview

13.3.5 GSK Latest Developments

13.4 Viatris

13.4.1 Viatris Company Information

13.4.2 Viatris Human Injection Flu Vaccine Product Offered

13.4.3 Viatris Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Viatris Main Business Overview

13.4.5 Viatris Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Human Injection Flu Vaccine Product Offered

13.5.3 AstraZeneca Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Hualan Bio

13.6.1 Hualan Bio Company Information

13.6.2 Hualan Bio Human Injection Flu Vaccine Product Offered

13.6.3 Hualan Bio Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hualan Bio Main Business Overview

13.6.5 Hualan Bio Latest Developments

13.7 Changchun Institute of Biological

13.7.1 Changchun Institute of Biological Company Information

13.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Offered

13.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Changchun Institute of Biological Main Business Overview

13.7.5 Changchun Institute of Biological Latest Developments

13.8 Sinovac

13.8.1 Sinovac Company Information

13.8.2 Sinovac Human Injection Flu Vaccine Product Offered

13.8.3 Sinovac Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sinovac Main Business Overview

13.8.5 Sinovac Latest Developments

13.9 Jiangsu GDK

13.9.1 Jiangsu GDK Company Information

13.9.2 Jiangsu GDK Human Injection Flu Vaccine Product Offered

13.9.3 Jiangsu GDK Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Jiangsu GDK Main Business Overview

13.9.5 Jiangsu GDK Latest Developments

13.10 KM Biologics

13.10.1 KM Biologics Company Information

13.10.2 KM Biologics Human Injection Flu Vaccine Product Offered

13.10.3 KM Biologics Human Injection Flu Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 KM Biologics Main Business Overview

13.10.5 KM Biologics Latest Developments

14 Research Findings and Conclusion

Table 1. Human Injection Flu Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Injection Flu Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Trivalent Influenza Vaccine

Table 4. Major Players of Quadrivalent Influenza Vaccine

Table 5. Global Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)

Table 6. Global Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Human Injection Flu Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Human Injection Flu Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Human Injection Flu Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)

Table 11. Global Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Human Injection Flu Vaccine Revenue by Application (2017-2022)

Table 13. Global Human Injection Flu Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Human Injection Flu Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Human Injection Flu Vaccine Sales by Company (2020-2022) & (Units)

Table 16. Global Human Injection Flu Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Human Injection Flu Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Human Injection Flu Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Human Injection Flu Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Human Injection Flu Vaccine Producing Area Distribution and Sales Area

Table 21. Players Human Injection Flu Vaccine Products Offered

Table 22. Human Injection Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Human Injection Flu Vaccine Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Human Injection Flu Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Human Injection Flu Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Human Injection Flu Vaccine Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Human Injection Flu Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Human Injection Flu Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Human Injection Flu Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)

Table 34. Americas Human Injection Flu Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Human Injection Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Human Injection Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)

Table 38. Americas Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)

Table 40. Americas Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Human Injection Flu Vaccine Sales by Region (2017-2022) & (Units)

Table 42. APAC Human Injection Flu Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Human Injection Flu Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Human Injection Flu Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)

Table 46. APAC Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)

Table 48. APAC Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)

Table 50. Europe Human Injection Flu Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Human Injection Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Human Injection Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)

Table 54. Europe Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)

Table 56. Europe Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Human Injection Flu Vaccine Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Human Injection Flu Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Injection Flu Vaccine Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Human Injection Flu Vaccine Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Human Injection Flu Vaccine

Table 66. Key Market Challenges & Risks of Human Injection Flu Vaccine

Table 67. Key Industry Trends of Human Injection Flu Vaccine

Table 68. Human Injection Flu Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Human Injection Flu Vaccine Distributors List

Table 71. Human Injection Flu Vaccine Customer List

Table 72. Global Human Injection Flu Vaccine Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Human Injection Flu Vaccine Sales Market Forecast by Region

Table 74. Global Human Injection Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Human Injection Flu Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Human Injection Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Human Injection Flu Vaccine Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Human Injection Flu Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Human Injection Flu Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Human Injection Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Human Injection Flu Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Human Injection Flu Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Human Injection Flu Vaccine Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Human Injection Flu Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Human Injection Flu Vaccine Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Human Injection Flu Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Human Injection Flu Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Human Injection Flu Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Human Injection Flu Vaccine Product Offered

Table 94. Sanofi Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. CSL Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. CSL Human Injection Flu Vaccine Product Offered

Table 99. CSL Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. CSL Main Business

Table 101. CSL Latest Developments

Table 102. GSK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. GSK Human Injection Flu Vaccine Product Offered

Table 104. GSK Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. GSK Main Business

Table 106. GSK Latest Developments

Table 107. Viatris Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Viatris Human Injection Flu Vaccine Product Offered

Table 109. Viatris Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Viatris Main Business

Table 111. Viatris Latest Developments

Table 112. AstraZeneca Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. AstraZeneca Human Injection Flu Vaccine Product Offered

Table 114. AstraZeneca Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. AstraZeneca Main Business

Table 116. AstraZeneca Latest Developments

Table 117. Hualan Bio Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Hualan Bio Human Injection Flu Vaccine Product Offered

Table 119. Hualan Bio Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Hualan Bio Main Business

Table 121. Hualan Bio Latest Developments

Table 122. Changchun Institute of Biological Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Changchun Institute of Biological Human Injection Flu Vaccine Product Offered

Table 124. Changchun Institute of Biological Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Changchun Institute of Biological Main Business

Table 126. Changchun Institute of Biological Latest Developments

Table 127. Sinovac Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Sinovac Human Injection Flu Vaccine Product Offered

Table 129. Sinovac Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Sinovac Main Business

Table 131. Sinovac Latest Developments

Table 132. Jiangsu GDK Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Jiangsu GDK Human Injection Flu Vaccine Product Offered

Table 134. Jiangsu GDK Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Jiangsu GDK Main Business

Table 136. Jiangsu GDK Latest Developments

Table 137. KM Biologics Basic Information, Human Injection Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. KM Biologics Human Injection Flu Vaccine Product Offered

Table 139. KM Biologics Human Injection Flu Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. KM Biologics Main Business

Table 141. KM Biologics Latest Developments

List of Figures

Figure 1. Picture of Human Injection Flu Vaccine

Figure 2. Human Injection Flu Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Injection Flu Vaccine Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Human Injection Flu Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Injection Flu Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Human Injection Flu Vaccine Sales Market Share by Type in 2021

Figure 12. Global Human Injection Flu Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Human Injection Flu Vaccine Consumed in 6 Months to 3 Years

Figure 14. Global Human Injection Flu Vaccine Market: 6 Months to 3 Years (2017-2022) & (Units)

Figure 15. Human Injection Flu Vaccine Consumed in > 3 Years

Figure 16. Global Human Injection Flu Vaccine Market: > 3 Years (2017-2022) & (Units)

Figure 17. Global Human Injection Flu Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Human Injection Flu Vaccine Revenue Market Share by Application in 2021

Figure 19. Human Injection Flu Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Human Injection Flu Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Human Injection Flu Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Human Injection Flu Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Human Injection Flu Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Human Injection Flu Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Human Injection Flu Vaccine Sales 2017-2022 (Units)

Figure 26. Americas Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Human Injection Flu Vaccine Sales 2017-2022 (Units)

Figure 28. APAC Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Human Injection Flu Vaccine Sales 2017-2022 (Units)

Figure 30. Europe Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Human Injection Flu Vaccine Sales 2017-2022 (Units)

Figure 32. Middle East & Africa Human Injection Flu Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Human Injection Flu Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Human Injection Flu Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Human Injection Flu Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Human Injection Flu Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Human Injection Flu Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Human Injection Flu Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Human Injection Flu Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Human Injection Flu Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Human Injection Flu Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Human Injection Flu Vaccine

Figure 63. Industry Chain Structure of Human Injection Flu Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles